HB 1224 allows certain minors to consent to specific health services without parental approval, including treatment for pregnancy, sexually transmitted infections, substance abuse, or sexual assault. Parents generally retain access to their minor child's medical records, but this right is limited when the minor uses the bill's self-consent provisions for the listed health conditions. Health professionals must make a reasonable attempt to notify parents for emergency care but are not required to inform them for most other services covered under the bill. The bill also protects health providers from liability when acting in good faith under these rules, ensuring minors' confidentiality in sensitive health matters.
Oklahoma's SB 773 regulates pharmacy benefit managers (PBMs) by prohibiting unfair practices that affect independent pharmacies and patients. It requires PBMs to pay independent pharmacies the same reimbursement rate for identical drugs as they pay PBM-owned pharmacies, banning "spread pricing" where PBMs charge plans more than they pay pharmacies. The bill also prohibits PBMs from charging pharmacies fees for claim submission, network enrollment, or claims processing, and restricts retroactive payment reductions except for fraud or audit errors. These changes directly impact PBMs, pharmacies, and health plans operating in Oklahoma, aiming to ensure fairer payment practices. The bill was vetoed by the governor but overridden by the legislature on May 29, 2025.
HB 1808, now law in Oklahoma, reforms health insurance prior authorization and step-therapy rules to improve patient access to medications. It requires insurers to grant exceptions to step-therapy protocols (where patients must try cheaper drugs first) if a medication is contraindicated, ineffective based on medical history, or causes harm - covering specific scenarios like prior adverse reactions or stability on a current treatment. The bill mandates insurers respond to urgent prior authorization requests within 24 hours and non-urgent requests within 2 business days, with requests deemed approved if deadlines are missed. It also ensures continuity of coverage for stable treatments when switching plans (90-day protection) and requires insurers to cover at least one readily available asthma controller medication per class without prior authorization.
SB 1135 allocates $100,000 from Oklahoma's General Revenue Fund to the Oklahoma Health Care Authority for the 2025-2026 fiscal year to support its operations. The bill declares an emergency to allow immediate implementation upon approval. This legislation provides specific funding for the Authority's duties without altering existing health insurance or tax policies.
SB 1141 allocates $100,000 from unallocated state general revenue funds to Oklahoma's Department of Mental Health and Substance Abuse Services for its existing statutory duties. The bill requires these specific funds to be used for mental health services without creating new programs or altering current service requirements. An emergency clause makes the law effective immediately upon passage, bypassing the typical governor's signature requirement. The bill became law on May 29, 2025, after being passed without gubernatorial action.
SB 146 expands mental wellness services provided by Oklahoma's Department of Public Safety to include retirees of public safety personnel (such as police and firefighters), in addition to current employees. It creates a dedicated revolving fund (Section 9102) to finance these services and strengthens privacy protections by prohibiting the sharing of individual mental health data without consent, while allowing aggregate data use for policy improvements (Section 9101). The bill also mandates that all Mental Wellness Division resources operate separately from other department divisions. These changes took effect November 1, 2025, after becoming law without the Governor's signature on May 29, 2025.
HB 2797 prohibits Oklahoma's Health Care Authority (OHCA) from using statistical methods like extrapolation to audit Medicaid home and community-based service claims, which could require providers to repay overpayments. It invalidates all past audits using these methods (January 2020-November 2025) and voids related repayment demands. The bill requires OHCA and the Department of Human Services to jointly develop new audit standards and provide training for providers by November 2027. It also mandates compliance with existing fraud reporting rules and updates audit responsibilities for Medicaid waiver programs.
HB 2793 allocates $8,000,000 from Oklahoma’s Progressing Rural Economic Prosperity Fund to establish an Emergency Medicine Revolving Fund, as created by prior legislation (HB 2784). This fund will support ongoing emergency medical services, directly affecting hospitals and emergency care providers across the state. The appropriation becomes effective July 1, 2025, and the bill declares an emergency to expedite implementation. The bill does not create new taxes or services but redirects existing state funds to this specific purpose.
HB 2777 allocates $20 million from Oklahoma's Opioid Lawsuit Settlement Fund to the state's Opioid Abatement Revolving Fund for opioid-related programs, and $1.25 million to local governments that did not sue opioid manufacturers. The bill directs these funds to be used for opioid abatement efforts, such as treatment and prevention services, without requiring new taxes. It becomes effective July 1, 2025, and was signed into law on May 29, 2025. The legislation uses existing settlement funds rather than creating new spending.
SB 789, now effective as of May 28, 2025, restricts how pharmacy benefit managers (PBMs) can audit pharmacies. It requires PBMs to give pharmacies 14 days' notice (30 days for wholesale audits), prohibits recouping funds for simple errors like typos, and allows pharmacies to use hospital/physician records or any drug purchase records (without date/source limits) to validate claims. The law also caps audits at 50 prescriptions per pharmacy annually and mandates that any recouped funds first be refunded to the patient. This directly affects pharmacies, PBMs, and patients by standardizing audit practices and protecting against unfair financial penalties.
